Press release
Successful Completion of Training as an IT Specialist at arvato Systems in Rostock
Top IT TrainingGütersloh/Rostock, Germany – Three IT specialist trainees at arvato Systems in Rostock successfully completed their training in early July by taking the final oral examination. The three will now support the development team at the Rostock facility.
Training has a long tradition at arvato Systems in Rostock. IT specialists have been trained for application development here since the site was founded in 1998. The eleventh class of trainees has just completed their training here. Four new arvato Systems trainees will begin training in Rostock on 1 August, which means 50 young colleagues have begun their training there.
The Chamber of Commerce and Industry in Rostock confirms that this decision was a wise one for arvato Systems. The company of IT experts have received the ‘Top Training Company’ award for a fifth year running. Over the past year, companies awarded this title have given trainees individual attention and encouragement, allowed their employees to work as instructors, for example, in honorary roles on various examination boards, and provided career guidance programs for students. The award allows the Chamber of Commerce and Industry in Rostock to acknowledge the training services these companies offer and, at the same time, encourages other companies to provide challenging training positions for young people.
-> http://karriere.arvato-systems.de/com.html
About arvato Systems
For over 30 years arvato Systems has been building a solid reputation as a systems integrator. We not only implement standard software but also offer tailor made, industry specific and individually developed solutions. More than 2,000 dedicated employees at 25 sites throughout the world are always there for their customers. . As a subsidiary of arvato AG, a leading European BPO provider belonging to Bertelsmann AG, we have the unique capability to create entire value chains and combine IT with arvato AG’s services to an integrated service offer from one source.The strength of arvato Systems is in the intelligent combination of systems integration and planning, operation and support. Our customers appreciate the way we bring in-depth industry know-how, cross-platform expertise, a true partnership approach and genuine entrepreneurial spirit to the table. Our solutions pave the way to your success. www.arvato-systems.com
arvato Systems
An der Autobahn 200
D-33333 Gütersloh
Marcus Metzner
Head of Marketing Services & Communication
Phone: +49 5241 80-88242
Fax: +49 5241 80-9568
press@arvato-systems.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Successful Completion of Training as an IT Specialist at arvato Systems in Rostock here
News-ID: 232039 • Views: …
More Releases for Rostock
PEComa Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Wo …
PEComa emerging therapies such as FYARRO (sirolimus protein-bound), and others are expected to boost the PEComa Market in the upcoming years.
DelveInsight has launched a new report on "PEComa - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the PEComa, historical and forecasted epidemiology as well as the PEComa market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Request for our…
PEComa Drugs Market Size 2032 | Sarcoma Oncology Research Center LLC, Aadi Biosc …
DelveInsight's "Perivascular epithelioid cell neoplasm (PEComa) Market Insights, Epidemiology and Market Forecast - 2032" report delivers an in-depth understanding of the PEComa, historical and forecasted epidemiology as well as the PEComa market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Key Takeaways from the PEComa Market Research Report
• Assessments as per DelveInsight's analysts showed that females are more affected by PEComa than…
Pyruvate Kinase Deficiency Market to Register Incremental Growth During the Fore …
DelveInsight's "Pyruvate Kinase Deficiency Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Pyruvate Kinase Deficiency Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).
The Pyruvate Kinase Deficiency market report covers emerging drugs, treatment practices, market share of individual therapies, and…
Hunter Syndrome Pipeline Insight Market Research Report 2020 | Shire, Regenxbio, …
Hunter Syndrome Pipeline Insight, 2020, report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Hunter Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Geography Covered
- Global coverage
Hunter Syndrome Understanding
Hunter Syndrome: Overview
Mucopolysaccharidosis type II (MPS II),…
Global Alport Syndrome Market Pipeline Insight- Insight, Growth Rate and Forecas …
The Alport Syndrome Market Report Provides An Overview Of Therapeutic Pipeline Activity And Therapeutic Assessment Of The Products By Development Stage, Product Type, Route Of Administration, Molecule Type, And MOA Type For Alport Syndrome Across The Complete Product Development Cycle, Including All Clinical And Nonclinical Stages. A Better Understanding of Disease Pathogenesis Contributing To The Development Of Novel Therapeutics For Alport Syndrome.
Get a sample copy of the report at-…
Berlin Heart engineer receives Joachim-Jungius-Award of Rostock University
Berlin, 22 November 2010. Dr. Andreas Arndt, a team leader at Berlin Heart has just received the Joachim-Jungius-award of Rostock University for his outstanding research work on the field of implantable heart assist devices.
In the context of his thesis, Dr. Arndt developed a fully automatic, physiological regulation of the blood flow for the currently available implantable assist device INCOR®. Thus, the flow of blood is able to adapt perfectly…